COMPASS-31
Composite Autonomic Symptom Score
The COMPASS-31 (Composite Autonomic Symptom Score) is a 31-item self-report questionnaire that measures the severity of autonomic symptoms across six domains: orthostatic intolerance, vasomotor function, secretomotor function, gastrointestinal symptoms, bladder function, and pupillomotor function. It was developed at the Mayo Clinic and published by Sletten and colleagues in 2012 as a shorter, more practical version of the original 169-item Autonomic Symptom Profile.
It is widely used in both clinical practice and research to screen for dysautonomia and to track autonomic symptom burden over time. It has been validated in multiple languages and is referenced in studies on POTS, diabetic neuropathy, and post-viral autonomic dysfunction including long COVID.
The questionnaire generates a weighted total score from 0 to 100, with higher scores indicating greater symptom severity. Each domain is scored separately and then weighted according to the original validation, so the total reflects the relative clinical importance of different symptom areas rather than simply adding up raw answers.
If you have a post-viral condition, POTS, ME/CFS, or suspected dysautonomia, the COMPASS-31 can help you quantify your symptom burden in a structured way. It is particularly useful for tracking changes over time and for bringing a concrete, standardised summary to clinical appointments. If your main concern is POTS specifically, the Malmö POTS Symptom Score is a newer 12-item score built for POTS with a 7-day recall window, the Orthostatic Grading Scale grades orthostatic intolerance in five questions, the Vanderbilt Orthostatic Symptom Score is rated while standing, and the NASA lean test records the heart-rate data a POTS assessment requires.
This is a free, interactive version. Complete it below and receive your weighted score immediately, broken down by domain. No sign-up or email is required.
Your COMPASS-31 score
Domain breakdown
| Domain | Your score | Max |
|---|
Your results over time
Complete this again in a few weeks and the change will show here.
Symptom scores change slowly. A monthly retake is enough to see a trend.
Your results are stored only in this browser, on this device. Nothing is sent to us or to anyone else. They will be lost if you clear this site's data, use a private window, or switch browser or device. You can delete them at any time.
Understanding your COMPASS-31 score
What the score measures
It measures how much you are affected by symptoms of autonomic dysfunction: problems with the nerves that control heart rate, blood pressure, sweating, digestion, the bladder and the pupils. Its 31 questions fall into six domains, which are weighted and added up to a total from 0 to 100. Higher means more symptoms.
Orthostatic intolerance counts for up to 40 points, gastrointestinal 25, secretomotor 15, bladder 10, and vasomotor and pupillomotor 5 each. It was distilled at the Mayo Clinic from a longer questionnaire using the answers of 405 healthy volunteers (Sletten et al. 2012), then checked in 66 people being assessed for nerve damage (Treister et al. 2015).
Yes. It is widely used in POTS and long COVID research. In an online survey of 160 women with POTS, the average score was 55.3.
Score bands
There is no agreed normal range or cut-off. The paper that introduced the COMPASS-31 did not publish a normal range or severity bands.
Instead there are reference points from individual studies:
| Score | What the study found | Source |
|---|---|---|
| 10 | Screening cut-off for small fibre neuropathy: caught 93% of cases, but also flagged most people without it | Treister 2015 |
| 20 | Threshold for moderate to severe symptoms; 66% of 2,314 adults with long COVID scored above it | Larsen 2022 |
| 30 | Best cut-off for separating biopsy-confirmed small fibre neuropathy from none | Treister 2015 |
| 55.3 | Average among 160 women with POTS in an online survey | Blitshteyn 2024 |
A score of 30 is not a diagnosis. In a study of 66 people being assessed for small fibre neuropathy, 30 best separated those whose skin biopsy confirmed it from those whose did not, sorting about three in four of each group correctly.
What a change in score means
No minimal important change has been published, so there is no agreed number of points that counts as a real change. Scores were very consistent when people filled it in twice, two weeks apart. Most questions ask about the past year, so read changes over months, and look for a change that holds across several results.
What it does not measure
No. It measures the symptoms you report, not how your nerves actually work. A diagnosis needs a clinician and, for POTS, heart rate and blood pressure measured lying and standing. Specialist tests such as a tilt table measure function directly, and in one study COMPASS-31 scores agreed only moderately with them.
If your orthostatic score is high, the NASA lean test records the readings a POTS assessment uses, and the Malmö POTS score and Vanderbilt score focus on symptoms when upright. The plain-language guide to post-viral autonomic dysfunction explains how these symptoms fit together.
Taking this to your GP or consultant
Bring your total, the date, the six domain scores and, if you have one, the trend (the history above can be copied as text). Most GPs will not know the COMPASS-31, so say what it is: a validated 31-question measure of autonomic symptoms from the Mayo Clinic. Autonomic, cardiology and neurology specialists are more likely to recognise it. Use it to support a request for assessment, such as a lying and standing heart rate and blood pressure check, not as evidence of a diagnosis. See the 30 bpm threshold explainer and preparing for a GP appointment.
Sources
- Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 2012;87(12):1196–201. Full text
- Okdahl T, et al. Supplementary material 3: COMPASS-31 items and scoring algorithm. BMJ Open 2021;11:e038677. Article
- Treister R, O'Neil K, Downs HM, Oaklander AL. Validation of the Composite Autonomic Symptom Scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy. Eur J Neurol 2015;22(7):1124–30. Article
- Larsen NW, et al. Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults. Front Neurol 2022;13:1012668. Article
- Blitshteyn S, et al. Sexual dysfunction in postural orthostatic tachycardia syndrome (POTS): a cross-sectional, case-control study. J Clin Med 2024;13(8):2274. Article